523 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Emergent Acquisitions

Emergent has acquired 12 companies and its latest acquisition was ADAPT Pharma, Inc. on Aug 2018

Unlock 9 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
ADAPT Pharma, Inc.

Aug 2018

Source »
$635M
Adapt Pharma is a developer of nasal spray for the emergency treatment of opioid overdose manifested by central nervous system depression.
PaxVax, Inc.

Aug 2018

Source »
$270M
PaxVax researches, develops, manufactures and commercializes vaccines to treat and prevent infectious diseases.

-

Raxibacumab, GSK

Oct 2017

Source »
undisclosed
-

-

ACAM2000® Business, Sanofi

Jul 2017

Source »
$97.5M
-

-

GC-072 (EV-035 Series), Evolva Holding SA

Dec 2014

Source »
$1.5M
-

Frequently Asked Questions about Emergent

  1. What companies did Emergent acquire?

    Companies acquired by Emergent include Adapt Pharma, PaxVax and

  2. How many acquisitions does Emergent have?

    Emergent has acquired 12 companies including Adapt Pharma, PaxVax and .

  1. How many acquisitions did Emergent make in 2018?

    In 2018 Emergent acquired 2 companies including Adapt Pharma and PaxVax.